- Filed
- Mar 19, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | FY 2024 · Mar 10, 2025 | 308.63M sh |
| Shares Diluted | FY 2024 · Dec 31, 2023 | 299.95M sh |
| Capex | FY 2024 · Dec 31, 2023 | $287.83K |
| Operating Cash Flow restated | FY 2024 · Dec 31, 2023 | −$1.6M |
| Cash And Equivalents | FY 2024 · Dec 31, 2023 | $41.01K |
| Current Liabilities | FY 2024 · Dec 31, 2023 | $1.5M |
| Total Liabilities | FY 2024 · Dec 31, 2023 | $4.59M |
| Current Assets | FY 2024 · Dec 31, 2023 | $76.76K |
| Total Assets | FY 2024 · Dec 31, 2023 | $1.03M |
| Eps Diluted | FY 2024 · Dec 31, 2023 | −$0.01 |
| Eps Basic | FY 2024 · Dec 31, 2023 | −$0.01 |
| Sga Expense | FY 2024 · Dec 31, 2023 | $1.34M |
| Rd Expense | FY 2024 · Dec 31, 2023 | $1.85M |
| Net Income | FY 2024 · Dec 31, 2023 | −$3.06M |
| Operating Income | FY 2024 · Dec 31, 2023 | −$3.19M |
| Stockholders Equity | FY 2024 · Dec 31, 2022 | −$2.36M |